BMO Capital analyst Sean Dodge initiated coverage of HealthEquity (HQY) with a Market Perform rating and $100 price target The firm is positive on the backdrop for health savings account account growth but views the shares as fully valued heading into a lower rate environment.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HQY:
- BMO Capital Maintains Hold Rating on HealthEquity Amid Strong EBITDA Growth and Valuation Concerns
- HealthEquity’s Strategic Initiatives and Market Opportunities Drive Buy Rating
- HealthEquity introduces GLP-1 telehealth, direct HSA enrollment platforms
- HealthEquity price target lowered to $120 from $125 at KeyBanc
- HealthEquity management to meet with KeyBanc